Alivio, Rumolo B.

HRN: 29-27-93  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/09/2026
07/16/2026
IV
4.5g
Q8h
CAP MR With Aspiration Component
Checking Initial Appropriateness 
07/10/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
07/10/2026
07/17/2026
IV
500mg
OD
COPD; R/O CAP
Checking Initial Appropriateness 
07/19/2026
MUPIROCIN 2%, 15G (TUBE)
07/19/2026
07/26/2026
TOPICAL
2%
TID
Wound On Left Ear
Checking Final Appropriateness 
07/19/2026
MUPIROCIN 2%, 15G (TUBE)
07/19/2026
07/26/2026
TOPICAL
2
BId
Wound On Ear
Checking Final Appropriateness 
07/21/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/21/2026
07/28/2026
IV
1000mg
Q24
Aspiration Pneumonia
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: